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Abstract: Avian influenza H5N1 has shown high mortality rate in human. Non-structural protein 1 (NS1) 
is a virulence factor of H5N1. Mutation at the 42nd residue within the RNA-binding domain (RBD) of 
NS1 dramatically changes the degree of pathogenicity of H5N1 in mice. We here studied the impact of 
this mutation on the function of RBD, and found that RBD with serine at the 42th residue binds double-
stranded RNA (dsRNA), whereas that with proline at the 42th residue does not. Analysis of structural 
models of the RBD proteins with S42 and P42 suggested remarkable difference in the structure of the 
dsRNA-binding interface, whereas structural analysis by analytical gel filtration and CD measurements 
did not indicate difference between those RBD proteins. Our results suggest that the single amino acid replacement induces a 
minor, but global structural change leading to the loss of function of NS1 thereby the change in the degree of pathogenicity.  
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1. INTRODUCTION 
 Since the outbreak of highly pathogenic avian H5N1 
influenza virus infection in humans in 2003, the World 
Health Organization (WHO) has reported a mortality rate of 
about 60% [1]. It is remarkable that most of the victims with 
high pathogenic influenza die within two weeks with rapid 
progress of pathology. In the case of the influenza pandemic 
that occurred in 2009, some patients infected with influenza 
showed severe respiratory failure similar to H5N1 infection. 
Liem, Kawachi and Nakajima et al. [2, 3] have reported that 
patients infected with H5N1 influenza virus develop severe 
acute respiratory distress syndrome (ARDS). It is presumed 
that the direct cause of death is respiratory failure caused by 
severe ARDS. The final pathological stage of severe ARDS 
by highly pathogenic influenza infection shows diffuse 
alveolar damage. In addition, several studies have reported 
evidences of cytokine storms in specimen of the patients 
with ARDS caused by H5N1 infection [4-6]. Thus, intense 
inflammatory responses with hypersecretion of cytokines are 
directly linked to the severe ARDS and subsequent death 
observed in patients infected with influenza virus H5N1. 
 The genome of influenza virus is composed of eight 
single-stranded RNA segments, so that the RNA segments 
can be exchanged between different strains of influenza virus 
in a host cell infected by multiple strains. A novel strain of  
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influenza can be easily created by such mechanism. Through 
this exchanging mechanism, it is possible that a high 
pathogenic gene from avian influenza virus (H5N1) is 
transferred to mammalian influenza viruses. 
 One of proteins from the viral genes expressed in a host, 
NS1, is implicated in the virulence and determination of host 
range [7-9]. NS1 suppresses the dsRNA-mediated interferon 
response to attenuate the innate immune system [10, 11]. On 
the other hand, it has been reported that NS1 induces 
secretion of huge amount of cytokines from A549 cells, 
which are human alveolar basal epithelial cell line, under 
oxidative stress [12]. Thus, NS1 may be a viral factor to 
induce cytokine storms in the patients infected by H5N1.  
 A/Duck/Guangxi/27/03 (DK/27), a subtype of H5N1 
virus, is reported to cause highly pathogenic infection to 
mammals, and contains a Ser residue at the 42nd residue of 
NS1 (S42 type) [13]. By contrast, another subtype, 
A/Duck/Guangxi/12/03 (DK/12), contains NS1 with a Pro 
residue at the 42nd residue (P42 type), and exhibits lower 
pathogenicity than DK/27. This mutation causes difference 
in the degree of suppression of the dsRNA-mediated 
interferon response between these strains. These together 
suggest that NS1 is a virulence factor for high pathogenicity 
of the H5N1 strain.  
 A polypeptide of NS1 is composed of two structural 
domains such as the RNA-binding domain (RBD) and the 
effector domain (ED) [14]. The crystal structure of the 
complex of RBD of the S42 type and dsRNA [15] shows that 
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S42 directly interacts with dsRNA through a hydrogen bond. 
In addition, the side chains of the R35 and R38 residues in 
the complex directly interact with dsRNA. Replacement of 
R35, R38 as well as R46 has negative impacts on the binding 
to dsRNA [16, 17]. Some of these basic residues should 
interact with dsRNA through electrostatic interactions in 
addition to hydrogen bonding. Thus, those residues are likely 
to interact with dsRNA more tightly than S42 [15]. However, 
replacement of the 42nd residue surprisingly has a greater 
impact on the degree of pathogenicity of H5N1 than that of 
R38 [13]. The mechanism underlying this observation is 
enigmatic.  
 Here we analyze differences in RBD between the S42 
and P42 types by means of biochemistry and molecular 
modeling in order to elucidate the molecular mechanism.   
2. MATERIALS AND METHOD  
2.1. Plasmid construction and purification of RBD 
 RBD(S) from PR8 was subcloned into pGEX-4T1 (GE 
Healthcare, Little Chalfont, UK) with a TEV protease 
cleavage site instead of a thrombin site [18]. The 42nd 
residue of RBD(S) was replaced with a Pro residue by site-
directed mutagenesis to produce RBD(P). Protein expression 
experiments were carried out using Rosetta 2 (DE3) (Merck 
Millipore, Billerica, MA). After centrifugation of disrupted E. 
coli cells by sonication, soluble extracts were loaded onto 
Glutathione Sepharose 4B equilibrated with 20 mM Tris/HCl 
pH7.7, 150 mM NaCl, 1 mM EDTA and 1 mM DTT. GST-
fusion proteins were digested in the column by AcTEV 
protease (Life Technologies, Waltham, MA). After 0.3% 
polyethylenimine treatment, sample solutions were loaded 
onto Source S 4.6/100 PE (GE Healthcare). 
2.2. Analytical gel filtration experiments 
 Gel filtration experiments were performed using an 
ÄKTA FPLC (GE Healthcare) and a Superdex 75 10/300 
column (GE Healthcare) equilibrated with 50 mM Na-Pi, 
100 mM NaCl. ~50 µM RBD proteins were loaded. Gel 
Filtration Calibration Kit LMW (GE Healthcare) was used 
for the calibration. 
2.3. CD measurements 
 CD spectra were recorded on a J-820 spectropolarimeter 
(Jasco, Tokyo, Japan) at room temperature. The solution 
compositions were ~5 µM RBD, 100 mM NaCl and 50 mM 
Na-Pi buffer (pH 7.0). 
 2.4. EMSA 
 16nt dsRNA was designed following Chien et al. [19] 
and purchased from Sigma-Aldrich (St. Louis, MO). The 
RBD dimers (1.0 µM) and dsRNA (2.5 µM) were incubated 
on ice in 8% glycerol, 2 unit/µl RNasin, 50 mM Tris/HCl 
pH8.0, 1 mM DTT, 100 mM NaCl and 0.1 mg/ml heparin 
for 20 minutes. 6x dsRNA loading buffer (BioDynamics 
Laboratory Inc., Tokyo, Japan) was added to the mixture to 
load onto a 15% polyacrylamide gel. Electrophoresis was 
carried out at 4 ºC in 44.5 mM Tris/Borate pH8.3 and 1 mM 
EDTA. 
2.5. Modeling Structures 
 Modeling of monomers of RBD(P) and RBD(S) was 
carried out with I-TASSER [20]. Dimerization of RBD(P) 
and RBD(S) was carried out with MZDOCK [21]. Docking 
between dsRNA and the dimer of either RBD(S) or RBD(P) 
was carried out with ZDOCK [22]. Energy minimization was 
carried out using Swiss PDB Viewer [23]. Buried surface 
Figure 1. The RBD protein experiments. 
(A) Alignment of the RBD sequences. Gray backgrounds indicate common amino acid residues among RBDs from DK/12, 
DK/27 and PR8. DK/12 and DK/27 contain P42 and S42, respectively. Black backgrounds indicate those uncommon among 
all the sequences. (B) The results from SDS-PAGE electrophoresis after purification. An arrow indicates bands of the RBD 
proteins. (C) Chromatograms of analytical gel filtration chromatography show the identical elution volumes between RBD(P) 
and RBD(S) (upper panel). Calibration of the gel filtration column was carried out to measure molecular weights of the RBD 
proteins (lower panel). Ve/V0 values of both of the RBD proteins were ~1.56, so calculated molecular weights were ~19.4 
kDa. (D) CD spectra show marginal difference between RBD(P) and RBD(S). 
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area between the RBD proteins and dsRNA was calculated 
with PRince [24]. Evaluation of the model structures was 
carried out with Procheck, Verify3D and ERRAT [25] [26] 
[27]. 
3. RESULTS 
3.1. Sample preparation of the RBD proteins 
 To compare characteristics of RBD with P42 (RBD(P)) 
and that with S42 (RBD(S)), we first produced the 
recombinant proteins. Sequences of RBDs are listed in Fig. 
1A. Both RBD(P) and RBD(S) were expressed stably as 
soluble fraction and successfully purified (Fig. 1B). 
Behavior of these proteins in the course of purification was 
stable and showed no difference. This implies that both 
RBD(P) and RBD(S) possess stable folds in aqueous 
solution. 
3.2. Biochemical structural analysis of the RBD proteins 
 Amino acid substitution in a protein can occasionally 
cause a change in the state of multimerization or formation 
of aggregation, leading to a change in the function. To 
examine the possibility of such a change between RBD(P) 
and RBD(S), we analyzed molecular weights of the RBDs in 
aqueous solution by using analytical gel filtration column 
chromatography (Fig. 1C). Elution volumes of these proteins 
were almost the identical so that this indicates that molecular 
weights of RBD(P) and RBD(S) are almost the identical. 
Results of calibration of the gel filtration column suggested 
that molecular weights of RBD(P) and RBD(S) in aqueous 
solution are 19.4 ± 0.2 and 19.4 ± 0.1 kDa, respectively. 
Because the molecular weight of a monomer of RBD 
calculated based on the amino acid sequence is ~8.5 kDa, 
both RBD(P) and RBD(S) are likely to be dimers in aqueous 
solution.   
 We measured CD spectra to investigate whether there is 
difference in the secondary structure contents of RBD(P) and 
RBD(S), and observed marginal difference between the 
spectra of those proteins (Fig. 1D). It was suggested that 
both RBD(P) and RBD(S) are rich in α-helices, because each 
of the spectra shows two negative peaks at 208 and 222 nm. 
Thus, RBD(P) and RBD(S) have similar contents of the 
secondary structure.  
 We did not observe remarkable structural difference 
between RBD(P) and RBD(S) from the results of gel 
filtration chromatography and CD spectra. We next 
investigated whether there is difference or not in the function.  
3.3. Binding analysis to dsRNA 
 In order to examine the binding ability of the RBD 
proteins to dsRNA, we carried out EMSA and found a shift 
of a band in the lane of RBD(S) but did not in the lane of 
RBD(P) (Fig. 2). These results indicated that RBD with Ser 
at the position 42 bound dsRNA, whereas that with Pro did 
not. In the complex structure between an S42 type of RBD 
and dsRNA (PDB code: 2ZKO), the hydroxyl group of S42 
binds to a ribosyl group of dsRNA [15]. Thus, S42 of 
RBD(S) from our construct was likely to bind to a ribosyl 
group of dsRNA. RBD(P) should not be able to form a 
corresponding hydrogen bond because RBD(P) replaces this 
Ser with Pro. RBD(P) would therefore lose at least one 
hydrogen bond compared with RBD(S). 
 RBD has basic residues such as R35 and R38 on the 
dsRNA-binding interface [15]. Replacement of these residues 
has negative impacts on the binding to dsRNA [16, 17]. R35 
and R38 are conserved in both RBD(S) and RBD(P). These 
Arg residues should play more important roles in the binding 
to dsRNA than S42 because of the charges of these residues, 
so we had expected that the binding ability of RBD should be 
more or less preserved with the replacement of S42 with P42. 
It was therefore unexpected that RBD(P) showed no binding 
to dsRNA, given RBD(P) lost only the sole hydrogen bond. 
Thus, we speculated that RBD(P) differs from RBD(S) in 
higher order structure in addition to the difference in the 42nd 
side chain. However, the biochemical data above showed that 
RBD(P) and RBD(S) are almost the same as to molecular 
weight and secondary structure contents in aqueous solution. 
As a consequence, it is still obscure by what mechanism the 
dsRNA-binding ability of RBD(P) and RBD(S) are different. 
Table 1 Statistics of model structures. 
  RBD(P) RBD(S)     
 
 
Procheck 
Favored 93.7% 93.5% 
Additionally 
allowed 
4.8% 6.5% 
Generously 
allowed 
0.0% 0.0% 
Disallowed 1.6% 0.0% 
Verify3D 79.17% 100% 
ERRAT 90.698 100 
 
Table 2 Statistics of the binding interfaces between the RBD 
proteins and dsRNA. 
 RBD(P) RBD(S)    
Interface 
Area (Å2) 
2021.9 2161.7 
Number of 
H-bonds 
6 11 
3.4. Molecular modeling 
 
 
 
Figure 2. EMSA of dsRNA with the RBD proteins. 
(A) EMSA of dsRNA with the same amount of RBD(P) and 
RBD(S). An arrow with an asterisk indicates a shifted band 
of dsRNA due to binding to RBD(S). (B) 1 µM dsRNA was 
incubated with 0, 0.2, 1.0, 10.0 µM RBD(S) (from left to 
right) before loading onto the gel. Density of shifted bands of 
16nt-dsRNA increased responsive to concentration of 
RBD(S).  
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 To further analyze difference in the dsRNA-binding 
mechanism between RBD(P) and RBD(S), we carried out 
molecular modeling of the RBD proteins. To produce a 
complex model between RBD(S) and dsRNA, we docked 
dsRNA to the dimer model. The models showed no problem 
in the evaluation of the model structures by Procheck, 
Verify3D and ERRAT (Table 1). Modeling RBD(P) and the 
RBD(P)-dsRNA complex was carried out by the identical 
method as that for modeling RBD(S) and the RBD(S)-dsRNA 
complex, respectively. Overall structures of the complexes of 
RBD(P)-dsRNA and RBD(S)-dsRNA are similar to each other  
(Fig. 3A).  
 Overall structures of the RBD(P) and RBD(S) models are 
also similar (Fig. 3B). RMSD between these models are 2.18 
Å for backbone Cα atoms. The RMSD values of the RBD(P) 
and RBD(S) models to the crystal structure (2ZKO.pdb) [15] 
are 1.99 and 1.02 Å, respectively. Monomers of RBD(P) and 
RBD(S) are composed of three α-helices called Helices 1, 2 
and 3. Both of the models of RBD(P) and RBD(S) are dimers 
and rich in α-helices, which is consistent with the results from 
the gel filtration chromatography and CD measurements.  
 A remarkable difference between RBD(P) and RBD(S) is 
relative angles of Helices 2. Helix 2 of a monomer is tilted to 
that of the other monomer in RBD(P) (Fig. 3B). By contrast, 
Helices 2 of RBD(S) are parallel to each other. As a 
consequence, relative locations of the residues composing the 
dsRNA-binding interface on Helices 2 are different between 
RBD(P) and RBD(S). In addition, the structures of Helices 2 
of the RBD models are different. Helix 2 of RBD(S) is 
composed of a typical α-helix, whereas that of RBD(P) has a 
disruption of the helix at the position of P42 (Fig. 3B). 
Because the dsRNA-binding interface of the RBD proteins is 
composed of Helices 2, such differences in the structure 
should have impact on the binding capability of the RBD 
proteins to dsRNA. 
 Calculated binding interface areas between RBD and 
dsRNA are 2021.9 and 2161.7 Å2 for the RBD(P)-dsRNA and 
RBD(S)-dsRNA complexes, respectively (Table 2). Thus, 
affinities by Van der Waals interactions between RBD and 
dsRNA are expected to be similar for those complexes. 
Numbers of hydrogen bonds between RBD and dsRNA are 6 
and 11 for the RBD(P)-dsRNA and RBD(S)-dsRNA 
complexes, respectively. This suggests that the stability of 
complex formation should be higher in the RBD(S)-dsRNA 
complex than in the RBD(P)-dsRNA complex, and is 
consistent with the result from the EMSA experiment in which 
only RBD(S) bound to dsRNA.   
 The guanidium group of R38 of RBD(S) is sandwiched by 
and interacts with two phosphate groups of dsRNA in the 
complex model of RBD(S)-dsRNA (Fig. 4A). R38 of RBD(P) 
 
 
 
Figure 3. Model structures of the RBD proteins. 
(A) Model structures of the RBD-dsRNA complexes. Dimer 
models of the RBD(P) (left panel) and RBD(S) (right panel) 
proteins are indicated as white ribbons, whereas dsRNAs are 
indicated as stick models. (B) Comparison of models of the 
RBD proteins. The models of RBD(P) (left panel) and 
RBD(S) (right panel) are depicted as ribbons. Helices 2 of 
each monomer are colored blue or brown. Helices 2 are tilted 
to each other in RBD(P), whereas those are parallel in 
RBD(S). Disruption in Helix 2 is circled (left panel).  
 
Figure 4. Difference in local structures of the RBD-dsRNA complexes. 
White, red, blue and yellow atoms in stick models indicate carbon, oxygen, nitrogen and phosphorus atoms, respectively. The 
RBD models are depicted as ribbon models. Important residues of the RBD proteins and entire dsRNA are displayed as stick 
models.  (A) The guanidium group of R38 of the RBD(S) model is sandwiched by two phosphate groups of dsRNA. R38 of 
the RBD(S) model forms hydrogen bonds with both of these phosphate groups. (B) R38 of the RBD(P) model is sandwiched 
by two phosphate groups of dsRNA, and interacts with one of these phosphate groups. Distance to the other phosphate group 
is too far to form a hydrogen bond.  (C) The hydroxyl group of S42 of the RBD(S) model interacts with a hydroxyl group 
protruding from a ribosyl group of dsRNA through a hydrogen bond. (D) P42 of the RBD(P) model lacks a hydroxyl group 
present in Ser, so that P42 cannot form a hydrogen bond with a neighboring phosphate group of dsRNA. 
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is also sandwiched by two phosphate groups of dsRNA, but 
interacts with only one of those phosphate groups (Fig. 4B). 
This phosphate groups is sufficiently close to R38 to form a 
hydrogen bond although the other one is not. The hydroxyl 
group of S42 of RBD(S) interacts with a hydroxyl group of a 
ribosyl group of dsRNA (Fig. 4C), whereas P42 of the RBD(P) 
model lacks a hydrogen bond to dsRNA (Fig. 4D). This is 
because a side chain of Pro lacks a hydroxyl group. R38 and 
T49 of the RBD(S) model also form hydrogen bonds to 
dsRNA, whereas those of RBD(P) lack these bonds. Taken 
together, several elements of the local structure implicated in 
the interaction between RBD and dsRNA are different 
between the RBD(P)-dsRNA and RBD(S)-dsRNA complex 
models. 
4. DISCUSSIONS 
 The mortality rate of patients infected with H5N1 
influenza virus in 2003 was reported to be approximately 
60% [1]. NS1 is a virulence factor contributing to high 
pathogenicity of H5N1, because the replacement of the 42nd 
residue on this protein causes critical change in the degree of 
pathogenicity [13]. NS1 is implicated in the occurrence of 
cytokine storms under oxidatively stressed conditions [12], 
which supports the proposal that NS1 is responsible for the 
high pathogenicity of H5N1 virus.  
 We carried out combined studies of biochemistry and 
molecular modeling to analyze the mechanical basis of high 
pathogenicity by NS1, and demonstrated that RBD(P) and 
RBD(S) share several common features as to their structural 
facets despite critical difference in the binding ability to 
dsRNA. Replacement of Ser at the 42nd residue with Pro is 
technically expected to lead to loss of a hydrogen bond 
because a side chain of Pro lacks a hydroxyl group. However, 
it is skeptical whether loss of only a hydrogen bond caused 
by the replacement of a Ser residue could lead to severe 
change in the degree of pathogenicity. This is because 
replacement of R38 to Ala shows much smaller impact on 
the pathogenicity [13]. 
 Taken together, it appeared difficult to analyze the 
mechanical basis of the difference in the degree of 
pathogenicity between RBD(P) and RBD(S) only through 
the results from our biochemical experiments and discussion 
as to the change of only the 42nd side chain. To address this 
problem, we modeled the structures of the complexes of 
RBD(P)-dsRNA and RBD(S)-dsRNA to observe global 
conformational changes of the RBD proteins in binding to 
dsRNA. Although the overall structures of RBD(P) and 
RBD(S) appear similar to each other, the relative angles of 
Helices 2 of the two monomers are different between these 
RBD models. In addition, Helix 2 of RBD(P) shows a 
disruption at P42. A disruption in an α-helix at a Pro residue 
is observed in other proteins [28]. By these changes in 
relation to the structure of Helix 2, the relative locations of 
the dsRNA-binding residues such as R35, R38 and T49 were 
predicted to be changed. Thus, it was suggested that the 
binding affinity at those dsRNA-binding residues as well as 
the 42nd residue becomes lower by such structural changes, 
leading to the entire loss of the affinity of RBD(P). These 
results collectively suggested that such global 
conformational change of RBD by the replacement of the 
42nd residue leads to the change in the degree of the 
pathogenicity of H5N1 influenza virus. 
 Numerous NS1 monomers form a huge polymer through 
dimerization mechanism at RBD and ED [29]. Our modeling 
results suggested a change in the dimer arrangement between 
RBD(P) and RBD(S), which might have an impact on the 
ability of NS1 to polymerize. It has been reported that RBD 
interacts with a variety of host proteins [14]. So, it is 
speculated that the structural change between RBD(S) and 
RBD(P) may cause changes in affinities to host proteins. 
These changes might also have impact on the degree of 
pathogenicity of H5N1. 
5. CONCLUSION 
 The present studies showed that the replacement of the 
42nd residue of NS1 has a direct impact on the binding to 
dsRNA, so that the 42nd residue should be responsible for 
the high pathogenicity of H5N1. Our structural models also 
suggested that the replacement causes structural change of 
RBD, leading to the change in the dsRNA-binding affinity. 
In addition, such structural change might alter the other 
characteristics of NS1, such as those of polymer formation 
and binding to other host proteins. The results from our 
analysis of the RBD mechanism suggested that alteration of 
the structure of RBD causes change in the degree of 
pathogenicity of H5N1. These findings may contribute to 
development of a new strategy for designing drugs with a 
novel mechanism of action, for example, a specific chemical 
chaperone that alters the structure of RBD.   
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